Search

everythinglearnresearchcommunity

for

Search:↓

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

Medical castration in prostate cancer patients can increase the risk of serious heart rhythm problems, so it's important to monitor heart activity during treatment.

Androgens increase cervical cancer risk and affect its development.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

SGK1 is important in cancer growth and treatment resistance, and targeting it could improve therapies.

Dermoscopy is an effective tool for accurately detecting skin cancers.

Some breast cancer treatments, like taxanes, can cause long-term hair loss.

Microneedles show promise for cancer diagnosis and treatment due to their minimally invasive nature and effective drug delivery.

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.

Bee venom shows promise for treating cancer, infections, inflammation, and hair loss.

Consult an oncologist before using supplements for hair loss during breast cancer treatment.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Neoadjuvant chemotherapy followed by surgery leads to fewer severe complications and better quality of life than immediate surgery in advanced ovarian cancer patients with high tumor load.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

A new method, iSiMPRe, effectively identifies key protein regions in cancer genes, highlighting potential drug targets.

Older women face various skin issues like dryness and thinning, and treatments are available but can have side effects; proper skin care and legal health decisions are important.

Lack of functional CYLD in mice leads to early aging and cancer.

PROTACs show promise for cancer treatment, but designing them effectively is challenging.

Paclitaxel is an effective cancer drug with side effects and potential new uses beyond cancer.

EMT and metabolic pathways help cancer cells resist treatment and spread.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

Scaffold-based drug delivery systems improve oral cancer treatment by targeting drugs directly to cancer cells, reducing side effects.

Cold Atmospheric Plasma shows promise in treating aggressive breast cancer by targeting cancer cells while sparing normal tissue.

Alopecia treatments like 5α-reductase inhibitors and spironolactone are safe for breast cancer patients and high-risk women.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

Honey and bee pollen can help reduce menopausal symptoms in breast cancer patients.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.